Immunofluorescence stainings revealed that the expression levels of epidermal stem cell markers (KRT14 and TP63) and mature epidermal marker (KRT10) were downregulated in scleroderma, while these proteins were recovered to normal levels in the treatment group (Figure 4e). Here, TP63 is linked to scleroderma.